The bwi product analysis lab received the device for evaluation on 05-aug-2021.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
Additional information was provided on 02-jul-2021 supplying extra concomitant products.Therefore, added the extra products to the "d10.Concomitant medical products and therapy dates" field.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
It was reported that a 45 year old male patient underwent an atrial fibrillation (afib) ablation procedure with thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered phrenic nerve paralysis.The device evaluation was completed on 14-oct-2021.The product was returned to biosense webster for evaluation.Bwi conducted a visual inspection and an evaluation of all features of the catheter.Visual analysis of the returned product revealed that no damage or anomalies were observed on the smart touch sf catheter.Per the event, several tests were performed.The magnetic, temperature and force features were tested and error 106 was displayed in the screen.In addition, the product was deflecting correctly and irrigation failed.Therefore, the catheter was dissected on the tip area, loss of electrical continuity of the green paired wires to sensor was found.Concluding that is an internal failure of the sensor.A failure analysis was performed and the catheter was dissected, and it was found the irrigation blocked with a foreign material.A fourier transform infrared spectroscopy test (ftir) was performed and the results showed foreign material is primarily composed of a biological-based material, human tissue or fluid.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.As part of bwi¿s quality process all devices are manufactured, inspected, and released to approved specifications.The instructions for use states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|